Overview
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme present in all living cells, essential for hundreds of metabolic processes. It plays a critical role in energy production, DNA repair, gene expression, and cellular communication.
NAD+ levels naturally decline with age, and this decline is associated with many hallmarks of aging. Restoring NAD+ levels has become a major focus of longevity research, with various precursors and direct NAD+ supplementation being explored.
Chemical Formula: C21H27N7O14P2
Mechanism of Action
NAD+ functions through multiple critical pathways:
Cellular Energy Production
- Essential cofactor in glycolysis
- Required for mitochondrial electron transport chain
- Enables ATP production (cellular energy currency)
- Supports metabolic flexibility
Sirtuin Activation
- Substrate for sirtuin enzymes (SIRT1-7)
- Sirtuins regulate aging and metabolism
- Influences gene expression and longevity pathways
- Supports mitochondrial biogenesis
DNA Repair
- Consumed by PARP enzymes during DNA repair
- Essential for maintaining genomic stability
- Protects against age-related DNA damage
- Supports cellular health and longevity
Cellular Signaling
- CD38 enzyme uses NAD+ for signaling
- Regulates calcium signaling
- Influences immune function
- Modulates inflammation
Research Summary
Aging and Longevity
NAD+ Decline with Age
- NAD+ levels decrease 50%+ by middle age
- Decline correlates with aging hallmarks
- Restoration improves markers of aging in animals
- Multiple tissues affected by decline
Animal Studies
- Extended lifespan in various models
- Improved metabolic function in aged mice
- Enhanced muscle function and endurance
- Protected against age-related diseases
Cognitive Function
| Finding | Model |
|---|---|
| Improved memory | Aged mice |
| Neuroprotection | Alzheimer's models |
| Enhanced mitochondrial function | Neuronal cultures |
| Reduced neuroinflammation | Various models |
Metabolic Health
Insulin Sensitivity
- Improved glucose tolerance in animal studies
- Enhanced insulin sensitivity
- Supported healthy metabolic function
- Benefits in diabetic models
Mitochondrial Function
- Enhanced mitochondrial biogenesis
- Improved oxidative phosphorylation
- Better cellular energy production
- Reduced oxidative stress
Key Limitations
- Most dramatic results in animal models
- Human clinical trial data still emerging
- Optimal delivery method debated
- Long-term effects not fully characterized
- Direct NAD+ has bioavailability challenges
Pharmacokinetics
| Parameter | Value |
|---|---|
| Half-life | Minutes (direct IV) |
| Bioavailability | Poor oral (direct NAD+) |
| Delivery | IV, subcutaneous, or precursors |
| Tissue distribution | All cells require NAD+ |
Note: Precursors (NMN, NR) often preferred for oral supplementation
Common Protocols
Note: NAD+ therapies are not FDA-approved for anti-aging. The following represents research community protocols.
Direct NAD+ Administration
IV Infusion (Clinical Settings)
- 250-750 mg IV over 2-4 hours
- Series of 4-10 sessions common
- Monthly maintenance sometimes used
- Administered in clinical settings only
Subcutaneous Injection
- 50-100 mg daily
- Self-administered
- Research community protocol
- More practical than IV
NAD+ Precursors (Oral)
NMN (Nicotinamide Mononucleotide)
- 250-1000 mg daily
- Sublingual or oral
- Popular oral option
NR (Nicotinamide Riboside)
- 300-600 mg daily
- Oral capsules
- Well-studied precursor
Timing
- Morning administration typical
- Some report energy effects (avoid evening)
- Consistent daily use for precursors
Side Effects
IV Infusion
- Chest tightness or pressure (during infusion)
- Nausea
- Headache
- Cramping
- Anxiety or restlessness (high doses)
- Flushing
Subcutaneous
- Injection site reactions
- Mild nausea
- Flushing
Oral Precursors
- Generally well-tolerated
- Mild GI upset possible
- Flushing (especially with niacin-based)
Safety Considerations
- IV should only be administered by professionals
- Start with lower doses
- Cancer considerations (NAD+ supports all rapidly dividing cells)
- Long-term safety data still accumulating
Interactions
Potential Interactions
- Chemotherapy (theoretical concern)
- Other NAD+ precursors (additive)
- Alcohol (depletes NAD+)
- Medications metabolized via NAD+-dependent enzymes
Contraindications
- Active cancer (theoretical concern)
- Pregnancy/nursing (insufficient data)
- Severe liver disease
- Children (not studied)
Community Insights
Aggregated from research community reports.
Commonly Reported Experiences
- Increased energy and alertness
- Improved mental clarity
- Better exercise recovery
- Enhanced sleep quality
- Reduced brain fog
- Improved mood
IV vs. Precursors
- IV: More immediate, pronounced effects
- IV: More expensive, requires clinic visits
- Precursors: Convenient, daily option
- Precursors: Effects build over time
Practical Tips
- IV infusion can be intense—start with lower doses
- Hydrate well before and after IV
- Oral precursors: consistency matters more than timing
- Combine with lifestyle factors (exercise, fasting increase NAD+)
Common Stacks
- NAD+ precursors + Resveratrol (sirtuin activation)
- NAD+ + Pterostilbene
- NAD+ + Metformin (longevity protocols)
- Part of comprehensive longevity regimens
References
-
Yoshino J, et al. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metab. 2018;27(3):513-528.
-
Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208-13.
-
Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-71.
-
Rajman L, et al. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metab. 2018;27(3):529-547.
-
Shade C. The Science Behind NMN–A Stable, Reliable NAD+ Activator and Anti-Aging Molecule. Integr Med (Encinitas). 2020;19(1):12-14.
-
Braidy N, et al. Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases. Antioxid Redox Signal. 2019;30(2):251-294.